From Bell Biotech Snippets from RBS "Near term milestones to watch * Tissue Therapies (TIS) - 2QCY11 - Sign licensing deal with large wound-care company. "Is this an old target or the 1QCY11 confused? Or is it something i've missed somewhere?
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint